Balmer Lawrie & Company Limited vs TTK Healthcare Limited

A side-by-side comparison of Balmer Lawrie & Company Limited (BALMLAWRIE) and TTK Healthcare Limited (TTKHLTCARE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Balmer Lawrie & Company Limited leads BALMLAWRIE vs TTKHLTCARE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

BALMLAWRIE takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

9.84
P/E ratio
22.27
1.44
P/B ratio
1.45
5.01%
Dividend yield
0.88%
₹16.18
EPS
₹46.48

Profitability

BALMLAWRIE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

13.37%
Return on equity
5.89%
18.14%
Return on capital
7.50%
12.91%
EBITDA margin
3.05%
9.95%
Net margin
7.66%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

5.53%
Revenue CAGR (3Y)
5.75%
17.18%
Profit CAGR (3Y)
-53.18%

Size & financial health

BALMLAWRIE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2,723 Cr
Market cap
₹1,459 Cr
₹2,717 Cr
Revenue
₹857 Cr
₹270 Cr
Net profit
₹66 Cr
0.04
Debt / equity
0.02
Balmer Lawrie & Company Limited
  • + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 53.8%", "Company is almost debt free."]
  • − []
TTK Healthcare Limited
  • + ["Company is almost debt free."]
  • − ["Company has a low return on equity of 6.8% over last 3 years."]
Balmer Lawrie & Company Limited full analysis TTK Healthcare Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.